Mode
Text Size
Log in / Sign up

Gout Should Be Considered in Atypical, Acute, Severe, Recurrent, Bilateral, or Mass-Associated Carpal Tunnel SyndromeGout can cause carpal tunnel syndrome in some patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider gout in atypical, acute, severe, recurrent, bilateral, or mass-associated CTS.

This systematic review examined carpal tunnel syndrome (CTS) attributed to gout, tophus, or monosodium urate deposition. It included 57 reports: 44 case reports or clinical-image reports, 12 case series, and 1 nonrandomized comparative study, involving at least 120 patients, 152 CTS wrists, and 146 gout-attributable wrists.

Causal certainty was categorized into three tiers: Tier 1 (direct local confirmation) in 41 reports, Tier 2 (anatomically supported) in 5, and Tier 3 (explicit report-level attribution) in 11. Open decompression with lesion treatment was the most frequently reported operative pattern.

The authors note that the evidence is predominantly case-based and hypothesis-generating. They also state that evidence is insufficient to determine a preferred tendon procedure. Adverse events, follow-up, and comparator data were not reported.

For practice, the authors suggest that gout should be considered in atypical, acute, severe, recurrent, bilateral, or mass-associated CTS. Given the case-based nature of the evidence, these findings should be interpreted as hypothesis-generating rather than definitive.

How this fits prior evidence

Prior coverage addressed Kinesio taping plus stretching for carpal tunnel syndrome, with cautious interpretation due to high loss to follow-up. This systematic review addresses a different clinical question: whether gout, tophus, or monosodium urate deposition may underlie CTS, particularly in atypical, acute, severe, recurrent, bilateral, or mass-associated presentations. It extends prior coverage by focusing on causal attribution and operative patterns rather than conservative therapy. The evidence base is predominantly case-based, with causal certainty categorized as Tier 1 in 41 reports, Tier 2 in 5, and Tier 3 in 11, and it does not establish a preferred tendon procedure.

When you think of gout, you likely imagine painful, swollen joints in the feet or fingers. However, some patients experience a different kind of pain: carpal tunnel syndrome. This happens when nerves in the wrist become compressed. A review of 57 reports involving at least 120 patients shows that gout can cause this specific wrist condition through the buildup of crystals or other deposits.

Doctors found that open decompression with lesion treatment was the most common way to treat these cases. The review looked at several levels of certainty to confirm the link between gout and the wrist issue. While the evidence is mostly based on individual cases and is still early, it highlights why doctors should look for gout when a patient has unusual or severe carpal tunnel symptoms.

Because the evidence is still mostly based on case reports, it is hard to say exactly what the best surgical approach is for the tendons involved. However, the findings suggest that gout is a key factor to consider for patients with recurring or severe wrist problems.

What this means for you:
Gout can cause carpal tunnel syndrome, and doctors should consider it in cases of severe or recurring wrist pain.

Common questions

Can gout actually cause carpal tunnel syndrome?

Yes, gout can cause carpal tunnel syndrome. A review of 57 reports involving at least 120 patients confirmed that gout, tophus, or crystals can lead to wrist nerve compression. Doctors suggest considering gout as a cause when a patient has atypical, acute, severe, or recurring carpal tunnel symptoms.

How is this type of carpal tunnel different?

This version of carpal tunnel is specifically linked to gout-related deposits or crystals in the wrist. While most cases are identified through reports, the study found that open decompression with lesion treatment was the most common surgical method used to treat these specific cases.

Is there a standard way to treat the tendons involved?

Because the current evidence is mostly based on case reports and is still in the early stages, there is not enough information yet to determine a single preferred procedure for the tendons involved. You should talk to your doctor about the best treatment for your specific situation.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedOct 2026
View Original Abstract ↓
BackgroundTophaceous gout is an uncommon but clinically important cause of secondary carpal tunnel syndrome (CTS), with lesions ranging from diffuse flexor tenosynovitis to intratendinous destruction and direct median nerve involvement.MethodsPubMed/MEDLINE, Scopus, and Web of Science Core Collection were searched through 23 July 2026, supplemented by Google Scholar, publisher-page verification, and citation searching. Human primary reports explicitly attributing CTS or wrist-level median neuropathy to gout, tophus, or monosodium urate deposition were eligible. Two reviewers independently screened records. Fifty-seven reports (27 complete/detailed and 30 limited clinical sources) formed the primary synthesis and underwent design-appropriate Joanna Briggs Institute appraisal; 12 bibliographic or translation-limited reports were retained as historical ancillary evidence. Primary reports were additionally classified post hoc by causal certainty.ResultsOf 478 database records, 302 unique records were screened, and 69 canonical reports were included. The 57-report primary synthesis comprised 44 case reports or clinical-image reports, 12 case series, and one nonrandomized comparative study, representing at least 120 patients, 152 CTS wrists, and 146 gout-attributable wrists. Sex was reportable for 117 patients, of whom 111 (94.9%) were male. Causal certainty was Tier 1 (direct local confirmation) in 41 reports, Tier 2 (anatomically supported) in 5, and Tier 3 (explicit report-level attribution) in 11. Post hoc sensitivity analyses retaining Tier 1 + 2 (n = 46) and then Tier 1 only (n = 41) did not change the principal qualitative interpretations. Open decompression with lesion treatment was the most frequently reported operative pattern, but evidence remained insufficient to determine a preferred tendon procedure. JBI findings are reported by design; 481 item-level judgments are retained only as an audit total.ConclusionGout should be considered in atypical, acute, severe, recurrent, bilateral, or mass-associated CTS. In surgically treated reports, decompression was commonly combined with individualized management of tophaceous and tendon disease. The evidence is predominantly case-based and hypothesis-generating and is insufficient to define a validated treatment pathway or preferred tendon procedure.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.